Archeon to raise €5.5 million series A led by Karot Capital, Majycc eSanté Invest and Daphni.

Archeon, a Besançon, France-based producer of range of of new generation medical ventilation devices, announced closing series A equity funding at €5.5 million ($6 million).

The money was raised locally from France, from investors led by Karot Capital, Majycc eSanté Invest and Daphni, and supported by the European Regional Development Fund (ERDF - European Social Fund for Franche-Comté and Massif du Jura), and by Bpifrance.

The proceeds will be used to access to new markets including North America and allow it to expand its range of medical ventilation devices to new pre-hospital and hospital uses.

Archeon, founded in 2018 by Alban De Luca and Pierre-Edouard Saillard, designed EOlife, a device to assist manual ventilation in cases of cardiorespiratory arrest, which is the leading cause of death worldwide and has a survival rate of less than 5%. The system automatically measures and analyses the patient’s respiratory variables in real time, to deliver enough oxygen while avoiding hyperventilation.